The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 3, 1999, Pages 976-981

  DiGiovine, Bruno ^a   Chenoweth, Carol ^a   Watts, Charles ^a   Higgins, Millicent ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW; CANDIDA ALBICANS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COST; ENTEROCOCCUS; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0032843745     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.3.9808145     Document Type: Article

References (29)

1. Pittet, D., and R. P. Wenzel. 1995. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch. Intern. Med. 155:1177-1184.
2. Pittet, D., D. Tarara, and R. Wenzel. 1994. Nosocomial bloodstream infection in critically ill patients. J.A.M.A. 271:1598-1601.
3. Rello, J., M. Ricart, B. Mirelis, E. Quintana, M. Gurgui, A. Net, and G. Prats. 1994. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes [see comments]. Intensive Care Med. 20:94-98.
4. Smith, R., S. Meixler, and M. Simberkoff. 1991. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 100: 164-167.
5. Forgacs, I. C., S. J. Eykyn, and R. D. Bradley. 1986. Serious infection in the intensive therapy unit: a 15-year study of bacteremia. Q.J.M. 60:773-779.
6. Anonymous. 1992. Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR Morb. Mortal. Wkly. Rep. 41: 783-787.
7. Haley, R. 1991. Measuring the costs of nosocomial infections: methods for estimating economic burden for the hospital. Am. J. Med. 91(Suppl. 3B):32S-38S.
8. Knaus, W. A., D. P. Wagner, E. A., Draper, J. E. Zimmerman, M. Bergner, P. G. Bastos, C. A. Sirio, D. J. Murphy, T. Lotring, A. Damiano, and F. E. Harrell, Jr. 1991. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619-1636.
9. Reina, A., G. Vazquez, E. Aguayo, I. Bravo, M. Colmenero, and M. Bravo. 1997. Mortality discrimination in acute myocardial infarction: comparison between APACHE III and SAPS II prognosis systems. PAEEC Group. Intensive Care Med. 23:326-330.
10. Cho, D. Y., and Y. C. Wang. 1997. Comparison of the APACHE III, APACHE II, and Glasgow Coma Scale in acute head injury for prediction of mortality and functional outcome. Intensive Care Med. 23: 77-84.
11. Douma, C. E., W. K. Redekop, J. H. van der Meulen, R. W. van Olden, J. Haeck, D. G. Struijk, and R. T. Krediet. 1997. Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J. Am. Soc. Nephrol. 8:111-117.
12. Bastos, P. G., X. Sun, D. P. Wagner, W. A. Knaus, and J. E. Zimmerman. 1996. Applications of the APACHE III prognostic system in Brazilian intensive care units: a prospective multicenter study. Intensive Care Med. 22:564-570.
13. Zauner, C. A., R. C. Apsner, A. Kranz, L. Kramer, C. Madl, B. Schneider, B. Schneeweiss, K. Ratheiser, F. Stockenhuber, and K. Lenz. 1996. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoring systems. Intensive Care Med. 22:559-563.
14. Friedland, J. S., J. C. Porter, S. Daryanani, J. M. Bland, N. J. Screaton, M. J. Vesely, G. E. Griffin, E. D. Bennett, and D. G. Remick. 1996. Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit [see comments]. Crit. Care Med. 24: 1775-1781.
15. Garner, J., W. Jarvis, and T. Emori. 1988. CDC definitions for nosocomial infections. Am. J. Infect. Control 16:128-140.
16. Le, C. T., and B. L. Lindgren. 1988. Computational implementation of the conditional logistic regression model in the analysis of epidemiologic matched studies. Comput. Biomed. Res. 21:48-52.
17. Hilton, J. 1996. The appropriateness of the Wilcoxon test in ordinal data. Stat. Med. 15:631-645.
18. Centers for Disease Control NNIS System. 1997. National Nosocomial Infections Surveillance (NNIS) Report. Data Summary from October 1986-April 1997, issued May 1997. Centers for Disease Control, Atlanta, GA. www.cdc.gov/ncidod/hip/Surveill/nnis.htm
19. Miller, P. J., and R. P. Wenzel. 1987. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J. Infect. Dis. 156:-471-477.
20. Edmond, M. B., J. F. Ober, D. L. Weinbaum, M. A. Pfaller, T. Hwang, M. D. Sanford, and R. P. Wenzel. 1995. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection [see comments]. Clin. Infect. Dis. 20:1126-1133.
21. Rose, R., K. J. Hunting, T. R. Townsend, and R. P. Wenzel. 1997. Morbidity/mortality and economics of hospital-acquired blood stream infections: a controlled study. South. Med. J. 70:1267-1269.
22. Spengler, R., and W. Greenough, III. 1978. Hospital costs and mortality attributed to nosocomial bacteremias. J.A.M.A. 240:2455-2458.
23. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1988. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642-2645.
24. Martin, M. A., M. A. Pfaller, and R. P. Wenzel. 1989. Coagutase-negative staphylococcal bacteremia: mortality and hospital stay [see comments]. Ann. Intern. Med. 110:9-16.
25. Schlesselman, J. J. 1982. Case-Control Studies. Oxford University Press, New York.
26. Pittet, D., N. Li, and R. P. Wenzel. 1993. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur. J. Clin. Microbiol. Infect. Dis. 12:813-819.
27. Roberts, F. J., I. W. Geere, and A. Coldman. 1991. A three-year study of positive blood cultures, with emphasis on prognosis. Rev. Infect. Dis. 13:34-46.
28. Raad, I., R. Darouiche, J. Dupuis, D. Abi-Said, A. Gabrielli, R. Hachem, M. Wall, R. Harris, J. Jones, A. Buzaid, C. Robertson, S. Shenaq, P. Curling, T. Burke, and C. Ericsson. 1997. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group [see comments]. Ann. Intern. Med. 127:267-274.
29. Maki, D. G., S. M. Stolz, S. Wheeler, and L. A. Mermel. 1997. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial [see commenls]. Ann. Intern. Med. 127:257-266.